Bioactive cell-hydrogel microcapsules for cell-based drug delivery.

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Drug Delivery Systems

Background:

• Cell encapsulation faces challenges in long-term drug release and mechanical stability of devices.
• Current calcium-alginate beads exhibit weak in vivo stability and lack biomimicry.
• Inactive biomaterials and inert scaffolds fail to replicate the physiological cell environment.

Purpose of the Study:

• To design biomimetic cell-hydrogel capsules for improved in vivo cell functionality and capsule mechanical stability.
• To investigate the potential of cell adhesion peptides and bimodal molecular weight distributions in enhancing capsule performance.
• To establish a novel system for sustained, controlled drug delivery from immobilized cells.

Main Methods:

• Fabrication of biomimetic capsules by coupling arginine glycine aspartic acid (RGD) peptide to alginate.
• Utilizing an alginate mixture with a bimodal molecular weight distribution for capsule formulation.
• In vivo assessment of long-term functionality and drug release from encapsulated cells.

Main Results:

• Biomimetic capsules promoted cell adhesion, enhancing mechanical stability of the cell-polymer system.
• Significantly prolonged in vivo long-term functionality and drug release of encapsulated cells.
• Achieved sustained erythropoietin delivery for 300 days without immunosuppressive protocols.
• Demonstrated controlled in vitro and in vivo drug delivery by managing cell dose within capsules.

Conclusions:

• Biomimetic cell-hydrogel capsules offer a promising microenvironment for de novo drug delivery.
• The developed system overcomes limitations of traditional cell encapsulation for long-term therapeutic applications.
• This approach enables sustained drug release and improved device stability, paving the way for advanced cell-based therapies.